Tag

Biomanufacturing

Evolving External Collaboration Models
LIFE SCIENCES, VIDEO

Evolving External Collaboration Models

Reviewing how our industry’s business partnerships have changed over time. How will this trend continue into the future? Dividing the work and sharing the burden: How should biopharmaceutical companies align their objectives of cost management, risk management, productivity, and growth? Maturing business relationships over time through common culture through two-way communication, collaboration, and cooperation Walking through examples of external collaboration: What works, what does not, and why? — Joanne Beck EVP, Global Pharmaceutical Development & Operations Celgene Corporation Dr. Joanne Beck is EVP Global Pharmaceutical Development and Operations at Celgene where she oversees the company’s Pharmaceutical Development, Global Manufacturing Operations,…

Continue reading
Accelerating Delivery of New Medicines
LIFE SCIENCES, VIDEO

Accelerating Delivery of New Medicines

Examining technologies, tools, and platforms to accelerate the pace of biopharmaceutical development How development velocity can affect clinical development and what we learn in this process Examining how acceleration impacts our quality, regulatory, and supply chain functions. How do we all keep pace? Understanding how acceleration affects data monitoring and analytics throughout the product lifecycle Discussing what steps we as an industry will need to take together to make this the new normal — Jerry Cacia SVP, Head Global Technical Development Genentech Jerry is responsible for Roche’s Global Technical Development organization. This scope includes responsibility for developing manufacturing processes and…

Continue reading
Boosting Traceability and Security in the Supply Chain with Serialization
LIFE SCIENCES, VIDEO

Boosting Traceability and Security in the Supply Chain with Serialization

What is serialization? Global serialization mandates Impact on manufacturing and the pharma supply chain Implementation challenges Technologies – Now and into the future — George Skillin Sr. Director – Global Engineering Pfizer George Skillin is the Senior Director of Pfizer Global Engineering, where he manages a team of 35 engineering professionals in the Process, Equipment, Automation Engineering disciplines and manages the Global Serialization and Industrial Control System Cyber Security Programs for Pfizer. George joined Pfizer in 2002 taking on a 2+ year international assignment as a member of the Site Leadership Team in conjunction with the design, construction, and start-up…

Continue reading
Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?
LIFE SCIENCES, VIDEO

Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving business goals to better manage times of product and economic uncertainty Putting theory into practice: Implementing key metrics to improve manufacturing flexibility — Uwe Buecheler Corporate SVP, Biopharmaceuticals Boehringer Ingelheim Uwe Buecheler, joint Boehringer Ingelheim (formerly Dr. Karl Thomae GmbH) in 1991. During his time at Boehringer Ingelheim he held different positions in Biopharmaceuticals in Regulatory Affairs, Biological Safety and…

Continue reading
Panel: The Global Talent War in Biomanufacturing
LIFE SCIENCES, VIDEO

Panel: The Global Talent War in Biomanufacturing

Learning about global talent trends influencing the job market for senior executives and those with critical, specialized skill sets Creating effective attraction, retention and development plans for top talent Navigating the generational talent gap in critical functions Understanding which leadership differentiators are needed to make it to Senior Executive and C-Level roles — Sanat Chattopadhyay EVP & President, Merck Manufacturing Division Merck Sanat Chattopadhyay is responsible for Merck’s worldwide manufacturing and supply operations supporting annual global sales revenues exceeding $40 billion. Merck is known as MSD outside of the U.S. and Canada. Sanat oversees a network of 50 pharmaceuticals, vaccines,…

Continue reading
Ready or Not, Digitization Will Transform Biomanufacturing
LIFE SCIENCES, VIDEO

Ready or Not, Digitization Will Transform Biomanufacturing

The Amazon-ization of Retail – How an industry-wide disruption unfolds The ongoing digitization of the Biopharma ecosystem – The transformation of drug delivery The Possible? Likely? Inevitable? Impacts on Tech Ops – Recent new roles analysis What it all means for Biomanufacturing leadership — Pascal Bécotte Global Leader – Operations & Supply Chain Practice Russell Reynolds Pascal leads the firm’s global Operations & Supply Chain Officers Practice and is a key member of the Healthcare and Industrial teams. He advises global clients on their overall talent strategy, particularly with respect to leadership assessment and succession planning. With more than 16…

Continue reading
Digital Transformation with Business Impact for Manufacturers
LIFE SCIENCES, VIDEO

Digital Transformation with Business Impact for Manufacturers

Chris Dobbrow, the Senior Vice President of Sight Machine, spoke at the Biomanufacturing World Summit in San Diego, CA in November 2016. His presentation was entitled: Digital Transformation with Business Impact for Manufacturers Proving that the most valuable data in manufacturing is from production itself Choosing the right goals and outcomes to make a difference Connecting disparate IT systems together into a unified whole Building a scalable approach for the enterprise, step-by-step: Start small to go big Understanding why data lakes and bespoke projects don’t scale Illustrating successful projects with concrete examples

Continue reading
A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build
LIFE SCIENCES, VIDEO

A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build

David Radspinner  spoke  on November 14th at the 2016 edition of the Biomanufacturing World Summit. His session was entitled, A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build. In March 2016, David Radspinner was appointed as the General Manager for the GEHC LS newly created BioPark business. Previously, in January of 2014, GE acquired the HyClone Cell Culture business and subsequently David was appointed as its Hold Separate Manager. David earned a PhD in Analytical Chemistry from the University of Arizona and has spent over 14 years working within the areas of…

Continue reading